Who is sponsoring NCT02216227?

NCT02216227 is sponsored by VA Office of Research and Development.

What condition does NCT02216227 study?

NCT02216227 studies Surgical Site Infection.

What drugs are being tested in NCT02216227?

Interventions: Mupirocin, Chlorhexidine gluconate, Cefazolin, Vancomycin, Nasal Povidone Iodine.

What is the status of NCT02216227?

NCT02216227 is currently COMPLETED.

Last reviewed 2026-03-31 · How we verify

Checklist to Prevent MRSA Surgical Site Infections

NCT02216227 NA COMPLETED Results posted

The goals of this project are 1) to assess the effectiveness and cost-effectiveness of the checklist to prevent MRSA SSIs among Veterans undergoing TJA or cardiac surgery, and 2) to assess barriers and facilitators to checklist implementation. Hypotheses: 1. The SSI checklist will be effective at reducing MRSA SSIs among total joint arthroplasty and cardiac surgery patients. 2. Implementation of the checklist will be associated with an overall reduction in SSIs caused by all pathogens. 3. The SSI Checklist will be cost-saving since it will prevent many expensive SSIs. 4. Preoperative MRSA testing will be a modifiable barrier to implementing the SSI checklist.

Details

Lead sponsor	VA Office of Research and Development
Phase	NA
Status	COMPLETED
Enrolment	23005
Start date	Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sun Feb 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Surgical Site Infection

Interventions

Mupirocin
Chlorhexidine gluconate
Cefazolin
Vancomycin
Nasal Povidone Iodine

Countries

United States